989 related articles for article (PubMed ID: 28426856)
1. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
2. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Das M; Ray KJ; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Sep; 135(9):987-991. PubMed ID: 28817744
[TBL] [Abstract][Full Text] [Related]
4. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
5. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
[TBL] [Abstract][Full Text] [Related]
6. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo.
Cho J; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Lin YB; Ray KJ; Lietman TM; Rose-Nussbaumer J;
Am J Ophthalmol; 2018 Aug; 192():142-145. PubMed ID: 29758184
[TBL] [Abstract][Full Text] [Related]
9. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
Oldenburg CE; Venkatesh Prajna N; Krishnan T; Rajaraman R; Srinivasan M; Ray KJ; O'Brien KS; Glymour MM; Porco TC; Acharya NR; Rose-Nussbaumer J; Lietman TM
Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
[TBL] [Abstract][Full Text] [Related]
10. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
Ray KJ; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Patel S; Das M; Shah R; Dhakhwa K; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
Am J Ophthalmol; 2018 May; 189():41-46. PubMed ID: 29438654
[TBL] [Abstract][Full Text] [Related]
11. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
12. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
13. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
16. Medical interventions for fungal keratitis.
FlorCruz NV; Evans JR
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004241. PubMed ID: 25855311
[TBL] [Abstract][Full Text] [Related]
17. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Raghavan A; Srinivasan M; O'Brien KS; Zegans M; McLeod SD; Acharya NR; Keenan JD; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Jun; 134(6):693-6. PubMed ID: 27054515
[TBL] [Abstract][Full Text] [Related]
18. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.
Ray KJ; Lalitha P; Prajna NV; Rajaraman R; Krishnan T; Srinivasan M; Ryg P; McLeod S; Acharya NR; Lietman TM; Rose-Nussbaumer J;
Am J Ophthalmol; 2017 Jun; 178():157-162. PubMed ID: 28385473
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
